Tarsons Products Q2 FY27 Results: Margin and Profit Trend

Track the latest Tarsons Products Ltd. share price on Univest.

This Tarsons Products Q2 results preview looks at the labware and life-sciences products maker's recent quarterly numbers ahead of its results for the quarter ended September 30, 2026. The most recent reported quarter, Jun 2026, showed a swing to a net loss alongside margin compression compared with the four quarters before it, and this preview covers those numbers factually. This Tarsons Products Q2 results outlook is based only on historical, already-reported figures.

Tarsons Products Q2 Results Date

The Tarsons Products Q2 results date for the September 2026 quarter has not been announced yet. Life-sciences and labware companies typically report September-quarter results in the October to November window, and Tarsons Products is expected to follow a broadly similar schedule once its board meeting is disclosed. Readers following the Tarsons Products Q2 results should note that no forward estimate is implied here.

Tarsons Products Q2 Results Expectations

Tarsons Products Q2 results expectations for FY27 should be built around the margin and profitability trend rather than a specific number, since no verified estimate for revenue or profit is available for this stock. The company's operating margin ran between roughly 26.8% and 29.2% across the four quarters from Jun 2025 through Mar 2026, before falling to 23.58% in Jun 2026, a quarter that also swung to a net loss of Rs 1.44 crore. Whether the September 2026 quarter shows a return closer to the earlier margin band, or a continuation of the Jun 2026 compression, is the main factual question, without assuming either outcome. The Tarsons Products Q2 results discussion above draws entirely on numbers the company has already disclosed.

Also read – Camlin Fine Sciences Q2 Results FY27 Preview

Previous Quarter (Jun 2026 / Q1 FY27) Performance

In the quarter ended June 2026, Tarsons Products reported revenue of Rs 110.24 crore, an operating profit of Rs 25.99 crore at a 23.58% operating margin, and a net loss of Rs 1.44 crore. This marked a swing to a net loss and the lowest operating margin of the five quarters in this data set, following a stronger Mar 2026 quarter. For context on the Tarsons Products Q2 results, the preceding quarterly figures are all historical, not projected.

Q2 FY26 (Sep 2025) Base Quarter

The year-ago quarter, Sep 2025, showed revenue of Rs 102.33 crore, an operating margin of 26.82%, and a net profit of Rs 3.32 crore. This profitable base quarter is what the September 2026 results will be compared against on a year-on-year basis. This section of the Tarsons Products Q2 results coverage relies solely on reported data, not analyst forecasts.

Recent Trend: Jun 2025 to Jun 2026

Revenue rose steadily from Rs 91.36 crore in Jun 2025 to Rs 102.33 crore in Sep 2025, Rs 107.89 crore in Dec 2025, and Rs 120.93 crore in Mar 2026, before easing to Rs 110.24 crore in Jun 2026. Operating margin followed a similar arc, from 27.04% up to a peak of 29.21% in Dec 2025, then down to 28.34% in Mar 2026 and 23.58% in Jun 2026. Net profit moved from Rs 1.78 crore in Jun 2025 up to Rs 5.04 crore in Dec 2025, before falling to Rs 4.18 crore in Mar 2026 and then to a net loss of Rs 1.44 crore in Jun 2026, the swing to loss noted above. The Tarsons Products Q2 results trend described here reflects only what has already been reported to exchanges.

Key Factors

The clearest factor in Tarsons Products' recent numbers is the margin compression and swing to a net loss reported in Jun 2026, after four straight quarters of positive net profit and operating margins above 26%. This is the latest reported data point available and is stated here as fact, not as a forecast of what comes next. As a labware and life-sciences products maker, the company's margins can be affected by input costs, product mix and export demand, all of which vary quarter to quarter. Any reader researching the Tarsons Products Q2 results should treat the figures above as historical reference points.

Valuation

Also read – Campus Activewear Q2 Results FY27 Preview

Tarsons Products trades at a price-to-earnings ratio of 149.34, with earnings per share of Rs 2.23. The price-to-book ratio is 2.8 against a book value of Rs 119 per share, return on equity is a modest 2.44%, and the debt-to-equity ratio is 0.62. The stock's CMP is Rs 332.85, within a 52-week range of Rs 164.45 to Rs 375, above its 50-day moving average of Rs 322.71 and well above its 200-day moving average of Rs 243.8. RSI reads 43.7. Market capitalisation is Rs 1,773 crore, and the company does not currently pay a dividend. As with the rest of this Tarsons Products Q2 results preview, the numbers cited are drawn from public filings.

What to Watch

For the Tarsons Products Q2 results in FY27, the key things to track are whether the operating margin recovers from the 23.58% level seen in Jun 2026 back toward the 27-29% band of the prior four quarters, and whether the company returns to net profit after the Jun 2026 loss. The elevated PE ratio of 149.34 also means the stock's valuation already reflects a fair amount of expectation around future earnings recovery. This Tarsons Products Q2 results outlook is based only on historical, already-reported figures.

Conclusion

Tarsons Products enters its Q2 FY27 reporting period after a Jun 2026 quarter that showed both margin compression and a swing to a net loss, following four quarters of steadier double-digit operating margins. This is a factual account of reported numbers only, not a projection for the September 2026 quarter, and readers should refer to the company's own results announcement once the date is confirmed. Readers following the Tarsons Products Q2 results should note that no forward estimate is implied here.

Track life-sciences and labware stocks by opening a demat account with Univest.

Open your Univest demat account to follow Tarsons Products' results as they are announced.

Get started with investing through a free Univest demat account.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell or hold any security. Univest is a SEBI-registered research analyst, registration number INH000013776. Figures cited are sourced from the company's reported financials and public exchange data as available at the time of writing and may change. Please read all related documents carefully and consult a SEBI-registered advisor before making any investment decision. Investments in securities are subject to market risks.

When is the Tarsons Products Q2 results date for FY27?

Ans. The Tarsons Products Q2 results date for the quarter ended September 2026 has not been announced yet. Results are typically reported between October and November. The Tarsons Products Q2 results discussion above draws entirely on numbers the company has already disclosed.

What are the Tarsons Products Q2 results expectations for FY27?

Ans. There is no numeric estimate available. The key factor to watch is whether the operating margin recovers from the 23.58% seen in Jun 2026 and whether the company returns to net profit after that quarter's loss. For context on the Tarsons Products Q2 results, the preceding quarterly figures are all historical, not projected.

Why did Tarsons Products report a net loss in Jun 2026?

Ans. Tarsons Products swung to a net loss of Rs 1.44 crore in Jun 2026 alongside margin compression to 23.58%, down from the 27-29% range seen in the four quarters before it. This is the latest reported data point. This section of the Tarsons Products Q2 results coverage relies solely on reported data, not analyst forecasts.

What is Tarsons Products' current valuation?

Ans. Tarsons Products trades at a PE ratio of 149.34 and a price-to-book ratio of 2.8, with return on equity of 2.44%. Market capitalisation is around Rs 1,773 crore.